RT Journal Article
SR Electronic
T1 Comparison of first trimester dating methods for gestational age estimation and their implication on preterm birth classification in a North Indian cohort
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2019.12.27.19016006
DO 10.1101/2019.12.27.19016006
A1 Ramya Vijayram
A1 Nikhita Damaraju
A1 Ashley Xavier
A1 Bapu Koundinya Desiraju
A1 Ramachandran Thiruvengadam
A1 Sumit Misra
A1 Shilpa Chopra
A1 Ashok Khurana
A1 Nitya Wadhwa
A1 GARBH-Ini
A1 Raghunathan Rengaswamy
A1 Himanshu Sinha
A1 Shinjini Bhatnagar
YR 2020
UL http://medrxiv.org/content/early/2020/05/09/2019.12.27.19016006.abstract
AB Background Different formulae have been developed globally for estimation of gestational age (GA) by ultrasonography in the first trimester of pregnancy. In this study, we develop an Indian population-specific dating formula and compare its performance with published formulae. Finally, we evaluate the implications of the choice of dating method on preterm birth (PTB) rate. The data for this study was from GARBH-Ini, an ongoing pregnancy cohort of North Indian women to study PTB.Methods Comparisons between ultrasonography-Hadlock and last menstrual period (LMP) based dating methods were made by studying the distribution of their differences by Bland-Altman analysis. Using data driven approaches, we removed data outliers more efficiently than by applying clinical parameters. We applied advanced machine learning algorithms to identify relevant features for GA estimation and developed an Indian population-specific formula (Garbhini-1) for the first trimester. PTB rates of Garbhini-1 and other formulae were compared by estimating sensitivity and accuracy.Results Performance of Garbhini-1 formula, a non-linear function of crown-rump length (CRL), was equivalent to published formulae for estimation of first trimester GA (limits of agreement, −46,0.96 weeks). We found that CRL was the most important parameter in estimating GA and no other clinical or socioeconomic covariates contributed to GA estimation. The estimated PTB rate across all the formulae including LMP ranged 11.54-16.50% with Garbhini-1 estimating the least rate with highest sensitivity and accuracy. While LMP-based method overestimated GA by three days compared to USG-Hadlock formula; at an individual level, these methods had less than 50% agreement in classification of PTB.Conclusions An accurate estimation of GA is crucial for management of PTB. Garbhini-1, the first such formula developed in an Indian setting, estimates PTB rates with higher accuracy especially when compared to commonly used Hadlock formula. Our results reinforce the need to develop population-specific gestational age formulae.Study questionIs there a need for an Indian population-specific GA estimation model?Do clinical and socioeconomic features affect the estimation of GA in the Indian population?Does the choice of a dating model affect the classification of PTB?What is already knownSeveral first trimester GA estimation formulae have been published based on different population globally.In India, CRL-based Hadlock’s formula, based on a US population, is primarily used for GA estimation.What this study addsWe have developed an Indian population-specific formula (Garbhini-1) for GA estimation in the first trimester.Garbhini-1 performs comparably to other published formulae in estimating GA with the highest balanced accuracy in classifying PTB.Other clinical and socioeconomic features do not improve the accuracy of the first trimester dating.Our results reinforce the need to develop population-specific GA formulae.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by an alumni endowment from Dr. Prakash Arunachalam to the Initiative for Biological Systems Engineering, IIT Madras (BIO/18-19/304/ALUM/KARH). GARBH-Ini cohort study is funded by Department of Biotechnology, Government of India (BT/PR9983/MED/97/194/2013) and for some components of the biorepository by the Grand Challenges India-All Children Thriving Program (supported by the Programme Management Unit), Biotechnology Industry Research Assistance Council, Department of Biotechnology, Government of India (BIRAC/GCI/0114/03/14-ACT).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll supplementary data used in the manuscript is submitted. Primary data can be shared according to the GARBH-Ini data sharing policy which available on request.